GB Patent

GB201912059D0 — Combaination therapy of a patient subgroup

Assigned to BerGenBio ASA · Expires 2019-10-09 · 7y expired

What this patent protects

Patent listed against cobimetinib-fumarate.

Drugs covered by this patent

cobimetinib-fumarate (COBIMETINIB FUMARATE)

Patent Metadata

Patent number: GB201912059D0
Jurisdiction: GB
Classification: —
Expires: 2019-10-09
Drug substance claim: No
Drug product claim: No
Assignee: BerGenBio ASA
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.